15 million J&J COVID Vaccines Thrown Away After Ingredient Mix-Up With AstraZeneca
The mix-up at a Baltimore manufacturing plant forced regulators to delay authorization of the plant’s production lines and prompted an FDA investigation.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed